UNIVERSITY PARK, Pa., July 17 -- Pennsylvania State University issued the following news release:
UNIVERSITY PARK, Pa. - From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval is often more nuanced than the headlines suggest.
In the following Q&A, Penn State researchers discussed the safety and availability of popularized drugs, what it takes for a new drug to be approved by the Food and Drug Administration (FDA) and what changes in drug policy mean for everyday Americans.
Q: With hearings by the Drug Enforcement Agency (DEA) on the proposed rescheduling of marijuana to Schedule II...